Subclinical carotid atherosclerosis in patients with psoriatic arthritis

scientific article published in September 2008

Subclinical carotid atherosclerosis in patients with psoriatic arthritis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/ART.24014
P698PubMed publication ID18759318
P5875ResearchGate publication ID23225638

P50authorGabriel Wai-Kwok YipQ42952251
P2093author name stringMartin Li
Cheuk-Man Yu
Brian Tomlinson
Edmund K Li
Lai-Shan Tam
Ying-Ying Leung
Tracy Y Zhu
Qing Shang
Emily W Kun
Tena K Li
Tanya T W Chu
Kong-Chiu Wong
Lai-Wa Kwok
Tracey Yu
P2860cites workAssociation of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993.Q40882910
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectatherosclerosisQ12252367
P304page(s)1322-1331
P577publication date2008-09-01
P1433published inArthritis & RheumatologyQ4797636
P1476titleSubclinical carotid atherosclerosis in patients with psoriatic arthritis
P478volume59

Reverse relations

cites work (P2860)
Q33706485Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.
Q44289756Arthritis as an important determinant for psoriatic patients to develop severe vascular events in Taiwan: a nation-wide study.
Q93173292Assessment of cardiac and vessel functions in childhood psoriasis
Q36993064Association Between Psoriasis and Subclinical Atherosclerosis: A Meta-Analysis
Q26783501Atherosclerosis in psoriatic disease: latest evidence and clinical implications
Q38185646Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis?
Q40069191Cardiometabolic Disorders in Psoriatic Disease
Q54255528Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients.
Q35557796Cardiovascular co-morbidity in patients with rheumatic diseases.
Q35974962Cardiovascular risk in patients with psoriatic arthritis
Q38124279Cardiovascular risk in the rheumatic disease patient undergoing orthopedic surgery
Q82734365Carotid intima-media thickness and serum leptin in psoriasis
Q37215912Carotid intima-media thickness in patients with mild or moderate psoriasis.
Q37198846Carotid plaque and bone density and microarchitecture in psoriatic arthritis: the correlation with soluble ST2
Q48339070Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical Needs.
Q35257745Cumulative inflammatory burden is independently associated with increased arterial stiffness in patients with psoriatic arthritis: a prospective study.
Q38165235Diagnosing and treating psoriatic arthritis: an update
Q44973053Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial
Q50705256Evaluation of serum sCD40L and homocysteine levels with subclinical atherosclerosis indicators in patients with psoriasis: a pilot study.
Q37690591Evaluation of subclinical atherosclerosis in Egyptian psoriatic patients.
Q39155260High prevalence of subclinical atherosclerosis in psoriatic arthritis patients: a study based on carotid ultrasound.
Q37672346Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis
Q46337002Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis
Q37987473Inflammation, atherosclerosis, and psoriasis.
Q41453068Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity
Q38972344Management of Cardiovascular Risk in Patients with Chronic Inflammatory Diseases: Current Evidence and Future Perspectives.
Q33730536Management of cardiovascular complications in systemic lupus erythematosus
Q84651042Mortality in Psoriatic Arthritis – A Single-center Study from the UK
Q24235971Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity
Q48252795Prevalence of cardiovascular risk factors in patients with psoriatic arthritis
Q34681057Prevalence of metabolic syndrome and degree of cardiovascular disease risk in patients with Psoriatic Arthritis
Q34420240Prognosis after percutaneous coronary intervention in patients with psoriasis: a cohort study using Danish nationwide registries
Q45717444Psoriasis and the Framingham risk score in a Danish hospital cohort
Q50552445Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.
Q37588346Psoriatic arthritis in Asia
Q35998182Risk of Cardiovascular Morbidity in Patients With Psoriatic Arthritis: A Meta-Analysis of Observational Studies.
Q50776527Serum complement C3 correlates with insulin resistance in never treated psoriatic arthritis patients.
Q38519523Targeting inflammation in the prevention of cardiovascular disease in patients with inflammatory arthritis.
Q34432846The burden of psoriatic arthritis: a literature review from a global health systems perspective.
Q37144730The impact of identifying carotid plaque on addressing cardiovascular risk in psoriatic arthritis
Q37873357The perspective on psoriatic arthritis in Asia
Q33584053The relationship between race, cigarette smoking and carotid intimal medial thickness in systemic lupus erythematosus
Q43488992The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study.
Q38264660Tumour necrosis factor inhibitors in the treatment of psoriatic arthritis: a view on effectiveness, clinical practice and toxicity
Q37118037Visualization of atherosclerosis as detected by coronary artery calcium and carotid intima-media thickness reveals significant atherosclerosis in a cross-sectional study of psoriasis patients in a tertiary care center
Q84514358[Development of morbidity and mortality in patients with spondyloarthritis]

Search more.